[HTML][HTML] Highlights of the 14th International Symposium on Sjögren's Syndrome

M Bombardieri, C Baldini, I Alevizos… - Clinical and …, 2018 - ncbi.nlm.nih.gov
The theme of the 14th International Sjögren's Symposium (ISSS) held in Washington DC,
between the 18th and the 21st of April, 2018 was “Paths to Precision Diagnosis and …

[PDF][PDF] One year in review 2019: Sjögren's syndrome

G Cafaro, C Croia, OD Argyropoulou… - Clin Exp …, 2019 - clinexprheumatol.org
Primary Sjögren's syndrome (pSS) is a complex and heterogeneous disorder characterised
by a wide spectrum of glandular and extra-glandular features. Novel insights into disease …

New developments in Sjögren's syndrome

L Kater, PCM de Wilde - Current opinion in rheumatology, 1992 - journals.lww.com
Sjögren's syndrome is an autoimmune exocrinopathy with characteristics of both organ-
specific and generalized autoimmune disease. The main features are keratoconjunctivitis …

Sjögren's syndrome: perspectives on pathogenesis and therapy

RI Fox, CM Fox - Indian Journal of Rheumatology, 2009 - journals.lww.com
During February of 2008, I had the honour of visiting medical centres in New Delhi, Mumbai,
and Bangalore. As part of lectures and patient care rounds, a number of questions about …

[引用][C] Fifth international symposium on Sjögren's syndrome

RI Fox - Arthritis & Rheumatism: Official Journal of the American …, 1996 - Wiley Online Library
More than 180 participants from 25 countries and 5 continents gathered at the Fifth
International Symposium on Sjogren's Syndrome, June 15-17, 1995 in Noordwijkerhout, The …

[PDF][PDF] Limited efficacy of targeted treatments in Sjögren's syndrome: why

AG Tzioufas, AV Goules - Clin Exp Rheumatol, 2018 - clinexprheumatol.org
Limited efficacy of targeted treatments in SS io fas o es the disease is advanced (2, 8).
Therefore, it is rational to assume that the expected therapeutic window has been narrowed …

Sjögren's syndrome: shedding light on emerging and key drug targets

D Ridgewell, N Thalayasingam… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Sjögren's syndrome (SS) is an immune-mediated inflammatory condition
characterized by sicca syndrome, musculoskeletal pain, and fatigue. Extra-glandular …

Sjögren's syndrome update: clinical and therapeutic aspects

G Nocturne - La Revue de Médecine Interne, 2019 - europepmc.org
Sjögren's syndrome (SS) is a systemic orphan disease. It is characterized by the
involvement of epithelial tissues leading to the term of autoimmune epithelitis. New …

Toward better outcomes in Sjögren's syndrome: the promise of a stratified medicine approach

G Noaiseh, AN Baer - Best practice & research Clinical rheumatology, 2020 - Elsevier
Sjögren's syndrome is a systemic autoimmune disease defined by its targeted inflammation
of the salivary and lacrimal glands, resulting in dry mouth and eyes in the majority and …

Sjögren's syndrome: viewpoint on pathogenesis

Y Kontinnen, L Käsnä-Ronkainen - Scandinavian Journal of …, 2002 - Taylor & Francis
Objective: To critically consider the public opinion/consensus on SS formulated by opinion
leaders and textbook chapters. Rationale: Although our clinical work is based on evidence …